Education and Training
- Resident, Medicine, Stanford University School of Medicine, 1990 - 1991
- Intern, Medicine, Stanford University School of Medicine, 1989 - 1990
- M.D., Stanford University, 1989
Beck, Benjamin, G Yancey Gillespie, Richard D. Lopez, Gretchen A. Cloud, Cathy Langford, Hyung Kim, Lualhati Harkins, and Lawrence S. Lamb. “Abstract 530: Circulating γδ T cells are activated and depleted during progression of high-grade gliomas: Implications for γδ T cells therapy of GBM.” Immunology, April 15, 2012. https://doi.org/10.1158/1538-7445.am2012-530.
Bryant, Nichole L., G Yancey Gillespie, Richard D. Lopez, James M. Markert, Gretchen A. Cloud, Catherine P. Langford, Hilal Arnouk, et al. “Preclinical evaluation of ex vivo expanded/activated γδ T cells for immunotherapy of glioblastoma multiforme..” J Neurooncol 101, no. 2 (January 2011): 179–88. https://doi.org/10.1007/s11060-010-0245-2.
Kanda, J., R. D. Lopez, and D. A. Rizzieri. “Alemtuzumab for the prevention and treatment of graft-versus-host disease.” International Journal of Hematology, 2011, 1–8.
Beck, Benjamin H., Hyung-Gyoon Kim, Hyunki Kim, Sharon Samuel, Zhiyong Liu, Robin Shrestha, Hilary Haines, Kurt Zinn, and Richard D. Lopez. “Adoptively transferred ex vivo expanded gammadelta-T cells mediate in vivo antitumor activity in preclinical mouse models of breast cancer..” Breast Cancer Res Treat 122, no. 1 (July 2010): 135–44. https://doi.org/10.1007/s10549-009-0527-6.
Bryant, Nichole L., Catalina Suarez-Cuervo, G Yancey Gillespie, James M. Markert, L Burt Nabors, Sreelatha Meleth, Richard D. Lopez, and Lawrence S. Lamb. “Characterization and immunotherapeutic potential of gammadelta T-cells in patients with glioblastoma..” Neuro Oncol 11, no. 4 (August 2009): 357–67. https://doi.org/10.1215/15228517-2008-111.
Liu, Zhiyong, Ben Guo, and Richard D. Lopez. “Expression of intercellular adhesion molecule (ICAM)-1 or ICAM-2 is critical in determining sensitivity of pancreatic cancer cells to cytolysis by human gammadelta-T cells: implications in the design of gammadelta-T-cell-based immunotherapies for pancreatic cancer..” J Gastroenterol Hepatol 24, no. 5 (May 2009): 900–911. https://doi.org/10.1111/j.1440-1746.2008.05668.x.
Liu, Zhiyong, Isam-Eldin A. Eltoum, Ben Guo, Benjamin H. Beck, Gretchen A. Cloud, and Richard D. Lopez. “Protective immunosurveillance and therapeutic antitumor activity of gammadelta T cells demonstrated in a mouse model of prostate cancer..” J Immunol 180, no. 9 (May 1, 2008): 6044–53. https://doi.org/10.4049/jimmunol.180.9.6044.
Suarez-Cuervo, C., N. L. Bryant, R. D. Lopez, G. Y. Gillespie, and L. S. Lamb. “Ex vivo activation and expansion of gamma delta T cells for immunotherapy of glioblastorna..” In Journal of Clinical Oncology, 24:113S-113S. AMER SOC CLINICAL ONCOLOGY, 2006.